Remove 2025 Remove BioTech Remove healthcare technology
article thumbnail

Doximity - the 'Linkedin for Doctors' is the best performing healthcare stock in 2025

Lloyd Price

Exec Summary As of February 23, 2025, Doximity (NYSE: DOCS), often dubbed the "LinkedIn for Doctors," has shown remarkable strength in the healthcare stock arena, positioning it as a standout performer this year. For the full fiscal year ending March 31, 2025, the company projects revenue between $564.6 million and $565.6

article thumbnail

HealthTech M&A Multiples March 2025: Current Trends and Variables driving valuations

Lloyd Price

Exec Summary: The HealthTech M&A landscape in 2025 is characterised by a mix of opportunity and caution. While innovative technologies continue to drive interest, financial discipline and strategic alignment are crucial for successful deals. The increase of distressed company M&A's is a large factor in the 2025 market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Wound Care: Emerging HealthTech market to watch in 2025

Lloyd Price

The wound care market is a dynamic and rapidly evolving sector, and 2025 is shaping up to be a pivotal year for innovation and growth in this field. The wound care market is poised for significant growth in 2025 and beyond. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

article thumbnail

HealthTech 2025: Key Priorities for Strategic, Financial Acquirers and Consolidators

Lloyd Price

Here are some of the key attributes they are looking for going into 2025: Technology with Disruptive Potential: Innovative Solutions: Acquirers are keen on technologies that can revolutionise healthcare delivery or patient experience. Several key trends are likely to drive these deals: 1.